NCT03162562 2020-12-22The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian CancerCanariaBio Inc.Phase 1 Terminated10 enrolled
NCT02452775 2020-04-24Autologous OC-L Vaccine and Ovarian CancerAbramson Cancer Center at Penn MedicinePhase 1 Terminated3 enrolled